Molecular diagnostics plays a crucial role in personalized medicine, allowing for the customization of treatment plans based on the unique genetic makeup of an individual's cancer. By identifying specific molecular targets, clinicians can select the most effective targeted therapies and avoid treatments that are unlikely to work, thereby improving outcomes and reducing unnecessary side effects.
